Back to search

Article

Astragaloside IV Reduces Mutant Ataxin-3 Levels and Supports Mitochondrial Function in Spinocerebellar Ataxia Type 3

2023-09-20

Abstract excerpt

<title>Abstract</title> <p>This study investigated the effects of astragaloside IV (AST) on the neurodegenerative disease of spinocerebellar ataxia type 3 (SCA3). Human neuroblastoma SK-N-SH cells expressing mutant ataxin-3 protein with 78 CAG repeats (MJD78) were used as an in vitro model, and SCA3 transgenic mice harboring an allele with a pathological polyglutamine tract with expanded 84 CAG repeats (SCA3 84Q)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a34da0c6-f9db-57d8-8df6-5192e3501b26
DOI
10.21203/rs.3.rs-3350835/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Astragaloside IV Reduces Mutant Ataxin-3 Levels and Supports Mitochondrial Function in Spinocerebellar Ataxia Type 3DOI 10.21203/rs.3.rs-3350835/v1
Select a neighboring publication to make it the new centre.